Vorlesung 2015

Medical Apps

Health Informatics World Wide

ResearchGate

Publikationen

Berger V, Scheinert A, Kasparu H, Koenig J, Krieger O, Roethlin M (2007) Palifermin as an effective prophylaxis of mucositis in lymphoma/all patients with BEAM conditioning. Bone Marrow Transplantation, pp S275-S275

Binder M, Koenig J, Krieger O, Kasparu H, Girschikofsky M, Zach O, Danzer M, Gabriel C, Lutz D (2007 / 05. - 09.10.) Non TBI-based Ric-transplantation in 42 patients with advanced or refractory/relapsed malignant diseases. Gemeinsame Jahrestagung DGHO, ÖGHO, SGHO, Basel

Binder M, Ziebermayr R, Girschikofsky M, Kasparu H, Koenig J, Krieger O, Weltermann A, Lutz D (2009) Low toxicity after chemoimmuno-conditioning in mantle cell lymphoma. Bone Marrow Transplantation, pp S215-S215

inder M, Ziebermayr R, Girschikofsky M, Kasparu H, Koenig J, Weltermann A, Krieger O (2009) Low Toxicity after Chemoimmuno-Conditioning in Mantle Cell Lymphoma. EBMT, Göteborg, Sweden, 29 March – 1 April 2009

Danzer M, Polin H, Proll J, Haunschmid R, Hofer K, Stabentheiner S, Hackl C, Kasparu H, Koenig J, Hauser H, Binder M, Weiss R, Gabriel C, Krieger O (2009) Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation. Transplantation 88:528-532

Girschikofsky M, Kasparu H, Krieger O, Koplmüller R, Koenig J, Lutz D (2000) Hämophagozytosesyndrom (HPS) im Erwachsenenalter – zwei Fälle mit letalem Ausgang. Acta Medica Austriaca 27

Gross H (2010) Moderne Informationstechnologie: Die Datenbank am Krankenbett. DMW 135:1525 [Interwiew, Podcast]

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Oberbauer R, Lutz D (2008) A single nucleotide polymorphism at chromosome 2q21.3 (LCT-13910C > T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation. Blood 112:2156-2159

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Oberbauer R, Lutz D (2008) A single nucleotide polymorphism at chromosome 2q21.3 (LCT -13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation. Blood 112:2156-2159

Hauser H, Zach O, Krieger O, Koenig J, Kasparu H, Girschikofsky M, Lutz D (2008) Association of donor and recipient LCT-13910 genotypes with outcome after allogeneic hematopoetic stem cell transplantation in AML and MDS-patients. Eur Surg 40

Hauser H, Zach O, Krieger O, Koenig J, Kasparu H, Girschikofsky M, Lutz D (2008) Association of donor and recipient LCT –13910 genotypes with outcome after allogeneic hematopoetic stem cell transplantation in AML and MDS patients. Acta Chir Aus 40

Hauser H, Zach O, Krieger O, Koenig J, Kasparu H, Girschikofsky M, Lutz D (2008) A single nucleotide polymorphism in a regulatory region of the lactase gene (LCT-13910 T/C) at chromosome 2q21.3 influences outcome after allogeneic stem cell transplantion. In: 34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, ITALY, pp S188-S188

Hauser H, Zach O, Krieger O, Koenig J, Kasparu H, Girschikofski M, Dieter L (2008 / 30.03. - 02.04.) A single nucleotide polymorphism in a regulatory region of the lactase gene (LCT –13910 T/C) at chromosome 2q21.3 influences outcome after allogeneic stem cell transplantion. EBMT, Florenz

Hauser H, Krieger O, Kasparu H, Koenig J, Lutz D, Zach O (2009) A single nucleotide polymorphism in the intelectin 1 gene (ITLN1) is associated with acute intestinal graft-vs.-host-disease. memo 2:18

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Weltermann A, Lutz D (2009) A single nucleotide polymorphism in the intelectin 1 gene (ITLN1) is associated with acute intestinal graft-versus-host disease. Bone Marrow Transplantation, pp S134-S134

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Lutz D (2010) Significant influence of LCT -13910 C>T on transplantation outcomes in acute myeloid leukemia patients receiving transplantations from HLA-identical sibling donors. Blood 115:3645-3646

Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Lutz D (2010) Response: Significant influence of LCT-13910C>T on transplantation outcomes in acute myeloid
leukemia patients receiving transplantations from HLA-identical sibling donors. Blood 115:3645 - 3646

Huber M, Binder M, Kasparu H, Koenig J, Krieger O, Lutz D (2008) Successful RIC-allo PBPCT in a patient with dyskeratosis congenita and bone marrow failure. memo Supplement 01/08

Kasparu H, Koplmüller R, Koenig J, Pichler J, Krieger O, Girschikofsky M, Schneider G, Lutz D (1999) Helicobacter pylori infection does not influence gastrointestinal toxicity after STX. Acta Chir Austriaca 31

Kasparu H, Koplmüller R, Kolb A, Koenig J, B. H, Girschikofsky M, Krieger O, Lutz D (2000) Mobilization, collection and reinfusion of autologous peripheral blood stem cells. Onkologie 23

Kasparu H, Koplmuller R, Kolb A, Koenig J, Haider B, Girschikofsky M, Langgartner M, Krieger O, Lutz D (2001) Factors influencing the harvest of sufficient numbers of CD 34+cells and their importance on hematopoietic reconstitution after autologous peripheral stem cell transplantation. Bone Marrow Transplantation 27:S347-S347

Kasparu H, Koplmüller R, Kolb A, Koenig J, Girschikofsky M, Langgartner M, Krieger O, Lutz D (2001) Prior chemotherapy schedules and disease status influence peripheral stem cell harvest. The Hematology Journal 1

Kasparu H, Koplmuller R, Ziebermayr R, Koenig J, Girschikofsky M, Krieger O, Lutz D (2002) Long-term follow-up of patients transplanted with CD 34+selected versus unselected stem cells for plasma cell disorders. Bone Marrow Transplantation 29:S102-S102

Kasparu H, Krieger O, Girschikofsky M, Koenig J, Koplmüller R, Ziebermayr R, Lutz D (2002) Doppeltransplantation bei Multiplem Myelom (MM) oder Morbus Hodgkin (MH). Acta Medica Austriaca 29

Kasparu H, Koenig J, Hauser H, Krieger O, Girschikofsky M, Bernhart M, Lutz D (2004) Autologous stem cell transplantation in patients with aggressive or follicular non-Hodgkin lymphoma between 8/1984 and 9/2003. 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, SPAIN, pp S254-S255

Kasparu H, Koenig J, Hauser H, Krieger O, Girschikofsky M, Bernhart M, Lutz D (2004) Autologous stem cell transplantation (ASCT) in 102 patients with aggressive or follicular non-Hodgkin´s lymphoma between 8/84 and 9/03 – a single center report. Bone Marrow Transplantation 33

Kasparu H, Koenig J, Krieger O, Girschikofsky M, Lutz D (2006) A single-centre experience in autologous stem cell transplantation for patients with multiple myeloma. In: 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group, Hamburg, GERMANY, pp S349-S349

Kasparu H, Koenig J, Krieger O, Girschikofsky M, Lutz D (2006) A single-centre experience in autologous stem cell transplantation for patients with multiple myeloma. Bone Marrow Transplantation 37

Koenig J, Dorda W, Erhart G (1996) Erfolgreiche Suche in medizinischen Datenbanken. SPRINGER, Wien, New York

Koenig J (2003) Medizinische Informationssuche. In: Robert T (ed) Wissenschaft und Medizin. FACULTAS, Wien, pp 111 - 128

Koenig J (2004) Medizinische Informationssuche. In: Robert T (ed) Wissenschaft und Medizin. FACULTAS, Wien, pp 113 - 158

Koenig J (2004 / 21.04.) Qualitätsmanagement in der Onkologie - Erfahrungen mit der elektronischen Chemotherapieplanung. Deutscher Internistenkongreß, Wiesbaden

Koenig J, Maieron A, Kasparu H, Krieger O, Lutz D (2005) Hyperkeratosen als Nebenwirkung einer Mucositisprophylaxe mit Palifermin. Eur Surg 37

Koenig J, Weltermann A (2012) Bridging mit neuen Antikoagulantien. Universum Innere Medizin 05:3

Koenig J (2013) Die Informationsflut beherrschen. krebs:hilfe! 6:2013:3

Koplmüller R, Kasparu H, Girschikofsky M, Koenig J, Krieger O, Lutz D (2000) CD 34 – selected versus non-selected peripheral stem cell transplantation after high-dose chemotherapy for patients with multiple myeloma. Bone Marrow Transplantation 25

Koplmüller R, Oppitz P, Krieger O, Kasparu H, Bettelheim P, Mitterbauer G, Mannhalter C, Haidenthaler A, Girschikofsky M, Koenig J, Kabicher G, Lutz D (2000) Allogeneic bone marrow transplantation in a patient with concomitant Ph+ C-ALL and CLL: a case report. Onkologie 23

Koplmüller R, Kasparu H, Ziebermayr R, Koenig J, Girschikofsky M, Krieger O, Lutz D (2002) Long-term Follow-up of Patients Transplanted with CD34+ Selected versus Unselected Stem Cells for Plasma Cell Disorders. Acta Medica Austriaca 29

Krieger O, Kasparu H, Girschikofsky M, Koplmüller R, Koenig J, Bettelheim P, Lutz D (1998) Cladribine (2-CDA) / Cyclophosphamide in indolent or relapsed chronic lymphocytic leukemia or other LG-NHL. Annuals of Hematology 77

Krieger O, Kasparu H, Girschikofsky M, Koplmüller R, Koenig J, Zach O, Bettelheim P, Dieter L (1998) Granulozytentransfusion (GTX) bei invasiver Aspergillose nach allogener Stammzelltransplantation. Acta Chirurgica Austriaca 30

Krieger O, Koenig J, Kasparu H, Girschikofsky M, Koplmüller R, Bettelheim P, Lutz D (1999) Beam conditioning +/- Amifostine in autologous stemcell-TX for high-risk lymphomas. Onkologie 22

Krieger O, Kasparu H, Girschikofsky M, Bernhart M, Koplmüller R, Koenig J, Lutz D (2000) Autologous stem cell transplantation in Non-Hodgkin lymphomas: A retrospective analysis of patients transplanted between 1984 and 1999. Bone Marrow Transplantation 25

Krieger O, Kasparu H, Koenig J, Zach O, Lutz D (2006) First experiences with a modified BEAC-conditioning in high risk ALL. Onkologie 29

Krieger O, Kasparu H, Binder M, Koenig J, Machhemdl-Spandl S, Zach O, Lutz D (2007) A modified BEAC-conditioning protocol: A safe and effective therapy for high risk ALL. 12th Congress of the European-Hematology-Association, Vienna, AUSTRIA, p 1193

Krieger O, Kasparu H, Koenig J, Machherndl-Spandl S, Zach O, Lutz D (2007) A modified beac-conditioning protocol: a safe and effective therapy for high-risk ALL. In: 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, FRANCE, pp S65-S65

Krieger O, Kasparu H, Koenig J, Machherndl-Spandl S, Zach O, Lutz D (2007) A modified beac-conditioning protocol: a safe and effective therapy for high-risk ALL. 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, FRANCE, pp S65-S65

Krieger O, Kasparu H, Koenig J, Machherndl-Spandl S, Zach O, Lutz D (2007) A modified beac-conditioning protocol: a safe and effective therapy for high-risk ALL. 33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, FRANCE, pp S65-S65

Krieger O, Kasparu H, Binder M, Koenig J, Machherndl-Spandl S, Zach O, Lutz D (2007 / 12. - 14.04.) A modified BEAC-conditioning protocol: a safe and effective therapy for high risk ALL. Frühjahrstagung ÖGHO, Wien

Krieger O, Kasparu H, Koenig J, Lutz D, Weltermann A (2009) A Heavily Pretreated Patient with Refractory Multiple Myeloma Successfully Treated with Bendamustine. Bendamustin Meeting, Barcelona / Spain

Machherndl-Spandl S, Krieger O, Kasparu H, Koenig J, Zach O, Lutz D (2006) First experiences with a modified BEAC-conditioning in high risk ALL. Eur Surg 38

Weltermann A, Girschikofsky M, Koenig J (2009) Focus Hämostaseologie. Spektrum Onkologie 02:73 - 74

Weltermann A, Koenig J (2009) Prophylaxe venöser Thromboembolien. Eine Gegenüberstellung: ACCP-Guidelines 2008 und S3-Leitlinie 2009. Universum Innere Medizin 05:48 - 50

Weltermann A, Girschikofsky M, Koenig J (2010) Focus: venoese Thromboembolie und Thrombophlebitis. Klinik Interdisziplinäre Zeitschrift für das Krankenhaus 02

Weltermann A, Girschikofsky M, Koenig J (2010) Focus venoese Thromboembolie und Thrombophlebitis. Spectrum Onkologie 01:56 - 57

Weltermann A, Koenig J (2010) Venoese Thromboembolien beim haematologischen Patienten. Spectrum Onkologie 03:100 - 102

Weltermann A, Koenig J (2010) Venoese Thromboembolien beim haematologischen Patienten. Universum Innere Medizin 05:15 - 17

Weltermann A, Koenig J (2010) Bluten für die neue Hüfte. Zwei neue orale Antikoagulantien haben die Zulassung für die Thromboembolieprophylaxe nach elektivem Knie- oder Hüftgelenksersatz erhalten. Ärztemagazin 35-36:10-13

Weltermann A, Koenig J (2010) Venoese Thromboembolie: Prophylaxe und Therapie beim Akutpatienten. Clinicum Das Magazin für die Führungskräfte im Krankenhaus 03:14 - 17

Zach O, Kasparu H, Krieger O, Girschikofsky M, Koplmüller R, Koenig J, Lutz D (1998 / 05. - 07.11.) Mammaglobin als molekularer Marker für den Nachweis zirkulierender Tumorzellen im peripheren Blut von Mammakarzinom Patientinnen. 15 Jahrestagung der Österreichischen Gesellschaft für Senologie, Innsbruck

Zach O, Kasparu H, Krieger O, Girschikofsky M, Koplmüller R, Koenig J, Lutz D (1998 / 30.10.) Mammaglobin as marker for the detection of circulating tumor cells in the peripheral blood of breast cancer patients via a nested RT-PCR assay. Proceedings: International Symposium: from Cell Morphology to Gene Therapy, Wien

Zach O, Krieger O, Kasparu H, Girschikofsky M, Koenig J, Hauser H, Kessler B, Lutz D (2004) Single Nucleotide Polymorphism (SNP) Real-Time PCR: Eine neue Methode für die Chimärismusanalyse nach allogener Stammzell-Transplantation. Acta Medica Austriaca 31

Zach O, Krieger O, Kasparu H, Girschikofsky M, Koenig J, Hauser H, Kessler B, Lutz D (2004) Single nucleotide polymorphism (SNP) real-time PCR: Eine neue Methode für die Chimärismusanalyse nach allogener Stammzell-Transplantation. Eur Surg 35